Study to compare the bioavailability of ABT-335 [choline fenofibrate] and rosuvastatin from ABT-143 [rosuvastatin/choline fenofibrate] relative to that from the co-administration of ABT-335 and rosuvastatin calcium
Phase of Trial: Phase I
Latest Information Update: 27 Sep 2012
At a glance
- Drugs Choline fenofibrate; Rosuvastatin; Rosuvastatin/choline fenofibrate
- Indications Hyperlipidaemia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors AstraZeneca
- 14 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Oct 2010 Actual end date (August 2008) added as reported by ClinicalTrials.gov.
- 10 Jun 2008 New trial record.